Generic Name and Formulations:
Trivalent inactivated "split virus" influenza vaccine (Types A and B); 0.1mL dose contains a total of 27mcg of influenza virus hemmagglutinin; formulation changes annually; susp for intradermal inj.
Sanofi Pasteur, Inc.
18–64yrs: One dose per year. 0.1mL intradermally in the region of the deltoid.
<18yrs: not recommended. Use Fluzone IM.
Allergy to egg proteins. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C for IM and High-Dose; Cat.B for Intradermal, Intradermal Quadrivalent). Nursing mothers.
Immunosuppressants: may get suboptimal response.
Local reactions (eg, pain, tenderness, swelling, erythema), malaise, headache, myalgia, irritability.
Fluzone, Fluzone Quadrivalent prefilled syringe (0.25mL, 0.5mL)—10; Single-dose vial (0.5mL)—10; Fluzone multi-dose vial (5mL)—1 (contains thimerosal); Fluzone High-Dose prefilled syringe (0.5mL)—10; Fluzone Intradermal, Fluzone Intradermal Quadrivalent single-dose prefilled microinjection system (0.1mL)—10
Join MIMS Learning now to manage all your CPD and notes in one place!
Already a MIMS Learning member?Sign In Now »
This red flags article explains signs and symptoms of potentially serious pathology in patients presenting...
This article by Dr Tillmann Jacobi covers the possible red flag symptoms to consider when a patient...
Dr Suneeta Kochhar provides an overview of red flag symptoms in patients presenting with headaches...
In this article, Dr David Brass and Dr Neil Rajan discuss the risk factors for BCC, making the diagnosis...
This article by Dr Rajiv Sankaranarayanan covers the diagnosis and management of cardiomyopathy. Key...
Dr Benjamin Simpson provides an in-depth overview of Parkinson’s disease, including information on risk...